COVID-19 Research Paper Volume 13, Issue 6 pp 7723—7732

Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019

Dynamic analysis of peripheral T-cell subsets in patients with different outcomes and endpoint times. (A, B) dynamic characteristics of peripheral CD3+CD4+ T cells (A) and CD3+CD8+ T cells (B) in improved patients with different endpoint times after therapy. (C, D) dynamic characteristics of peripheral CD3+CD4+ T cells (C) and CD3+CD8+ T cells (D) in exacerbated or dead patients with different endpoint times after therapy.

Figure 3. Dynamic analysis of peripheral T-cell subsets in patients with different outcomes and endpoint times. (A, B) dynamic characteristics of peripheral CD3+CD4+ T cells (A) and CD3+CD8+ T cells (B) in improved patients with different endpoint times after therapy. (C, D) dynamic characteristics of peripheral CD3+CD4+ T cells (C) and CD3+CD8+ T cells (D) in exacerbated or dead patients with different endpoint times after therapy.